Table 5.
Factors associated with mortality due to COVID-19 among the study participants.
| Variables | Odds ratio (95% CI) | p |
|---|---|---|
| Age in years | ||
| 18–35 | 1.0 | |
| 36–40 | 1.4 (0.1–14.1) | 0.773 |
| ≥50 | 8.6 (1.1–69.2) | 0.042 |
|
| ||
| Sex | ||
| Female | 1.0 | |
| Male | 0.9 (0.3–2.4) | 0.805 |
|
| ||
| Occupation | ||
| Formal | 1.0 | |
| Unknown | 0.5 (0.1–2.5) | 0.395 |
|
| ||
| Comorbidities | ||
| None | 1.0 | |
| At least one | 3.2 (1.1–8.9) | 0.029 |
|
| ||
| Hypertension | ||
| No | 1.0 | |
| Yes | 3.2 (1.2–8.6) | 0.024 |
|
| ||
| Diabetes mellitus | ||
| No | 1.0 | |
| Yes | 2.9 (1.0–8.5) | 0.056 |
|
| ||
| HIV | ||
| No | 1.0 | |
| Yes | 4.1 (0.4–47.8) | 0.258 |
|
| ||
| Others | ||
| No | 1.0 | |
| Yes | 1.5 (0.3–7.3) | 0.625 |
|
| ||
| Symptoms at admission | ||
| Asymptomatic | 1.0 | |
| Symptomatic | 0.2 (0–2.8) | 0.258 |
|
| ||
| Vitals at admission | ||
| Systolic blood pressure | 1.0 (1.0–1.0) | 0.879 |
| Diastolic blood pressure | 1.0 (0.9–1.0) | 0.123 |
| Heart rate | 1.0 (1.0–1.0) | 0.207 |
| Respiratory rate | 1.1 (1.0–1.2) | 0.002 |
| Temperature | 1.2 (0.7–2.2) | 0.511 |
| Random blood sugar | 1.0 (0.8–1.2) | 0.945 |
| SpO2 <92 | 5.1 (1.8–14.4) | 0.002 |
|
| ||
| Medications | ||
| Azithromycin | 0.9 (0.3–3.1) | 0.923 |
| Dexamethasone | 1.2 (0.4–3.5) | 0.773 |
| Vitamin C | 0.7 (0.2–2.2) | 0.518 |
| Vitamin D | 0.7 (0.2–2.2) | 0.518 |
| Enoxaparin | 0.4 (0.1–1.6) | 0.219 |
| Zinc | 1.0 (0.3–2.8) | 0.968 |
| Ulinastatin | 0.9 (0.3–2.6) | 0.919 |
| Ivermectin | 0.2 (0.1–0.6) | 0.004 |
| Remdesivir | 0.2 (0.1–0.9) | 0.030 |